Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2025-11-03 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
股东减持股份计划公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from Beijing Tianzhihang Medical Technology Co., Ltd. regarding a shareholder share reduction plan. It details the shareholders involved, their shareholdings, the planned reduction quantities, methods, periods, and related risk disclosures. The content focuses on the shareholders' intentions to reduce their holdings and the regulatory compliance of such actions. There are no financial statements, earnings data, or management discussions typical of financial reports. The document is not a report itself but an announcement about a shareholder transaction plan. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about share repurchases or sales by shareholders. The document length is about 4,117 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2025-11-03 Chinese
2025年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "北京天智航医疗科技股份有限公司 2025 年第三季度报告" which translates to "Beijing Tianzhihang Medical Technology Co., Ltd. 2025 Third Quarter Report." It contains detailed financial data for the third quarter of 2025, including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance. The report explicitly states it is unaudited and covers the quarter ending September 30, 2025. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length (13,478 characters) and content confirm it is the full report, not just an announcement or summary. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2025
2025-10-29 Chinese
2023年限制性股票激励计划首次及预留授予部分第二个归属期归属结果暨股份上市公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Beijing Tianzhihang Medical Technology Co., Ltd. regarding the listing of shares related to the 2023 restricted stock incentive plan's second vesting period. It details the number of shares vested, the decision-making process, the stock listing date, and the impact on share capital and recent financial results. The document includes specific dates, share quantities, and references to board and shareholder meetings approving the stock incentive plan. It is a formal disclosure about the issuance and listing of shares under a stock incentive plan, including share capital changes and registration details. This type of document is best classified as a Share Issue/Capital Change announcement (SHA), as it concerns new shares issued and their listing, rather than a full financial report or management discussion. The document length is under 5,000 characters, but it contains detailed information about the share issuance and listing, not merely a notice of report publication. Therefore, the appropriate classification is SHA with high confidence.
2025-10-21 Chinese
2025年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2025 second extraordinary general meeting of shareholders of Beijing Tianzhihang Medical Technology Co., Ltd. It details the meeting date, location, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholders' meeting. There is no indication of it being a full annual or interim report, audit report, earnings release, or other financial report. It is not a proxy solicitation or presentation but an official announcement of voting results from a shareholders' meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, consistent with DVA filings.
2025-10-16 Chinese
2025年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of the 2025 second extraordinary general meeting of shareholders of Beijing Tianzhihang Medical Technology Co., Ltd. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes on specific proposals. The document does not contain financial statements or performance data but focuses on the legality and validity of the shareholder meeting and its resolutions. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2025-10-16 Chinese
2025年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2025 年第二次临时股东大会会议资料" which translates to "2025 Second Extraordinary General Meeting (EGM) Materials." It contains detailed meeting instructions, agenda items, proposals for shareholder approval, voting procedures, and candidate information for board election. The content is clearly materials prepared for a shareholders' meeting, including agenda and proposals to be voted on. It is not a report of voting results, nor a notice of meeting, but the actual meeting materials. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is 4086 characters, which is short but contains substantive meeting materials, not just an announcement or notice. Therefore, the correct classification is AGM Information (AGM-R).
2025-10-10 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.